TENX — Tenax Therapeutics Inc · P/E 3.4, $24.1M cap

Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.

Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.

Use this TENX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TENX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TENX SEC filings page. Lician reads the product cache first so this HTML stays unique to Tenax Therapeutics Inc even when a live quote feed is slow.

Tenax Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full TENX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$52.6M
  • Total Assets$104.2M
  • Total Debt$0
  • Free Cash Flow$0

TENX recent filings